Towards the synthesis and delivery of a halogenated MCT1 substrate
<p>The monocarboxylate transporter 1 (MCT1) has received special attention as a potential therapeutic target in cancer thanks to its role in lactate shuttling. In breast cancer (BC), high MCT1 expression has been correlated with basal-like phenotype and a ‘triple-negative’ status, an aggressiv...
المؤلف الرئيسي: | |
---|---|
مؤلفون آخرون: | |
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
2019
|
الموضوعات: |